Sara M. Mangsbo - Concepedia

Author

Sara M. Mangsbo

Also Known As

Mangsbo, Sara M., S M Mangsbo, S Mangsbo, S. M. Mangsbo, S. Mangsbo, S.M. Mangsbo, Sara M Mangsbo, Sara M. Mangsbo, Sara Mangsbo

161

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Science for Life Laboratory Karolinska Institutet Uppsala University Hospital KTH Royal Institute of Technology

About

Sara M. Mangsbo is an author at Uppsala University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.1K
2	Allergy	5	5	283
3	Engineering	1	1	34
4	Biomedical Engineering	1	1	34
5	Biostatistics	1	1	34

Sara M. Mangsbo

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers Sebastian Havervall, Axel Rosell, Mia Phillipson, JAMA	2021	411
Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy Sara M. Mangsbo, Linda C. Sandin, Kerstin Anger, Journal of Immunotherapy Pd-1 BlockadeImmunologyImmunodominanceImmune Cell TherapyImmunotherapy	2010	191
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma Luuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran, Nature Communications	2021	142
Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages Fredrik Eriksson, Panagiotis Tsagozis, Kajsa Lundberg, The Journal of Immunology Tumor-associated MacrophagesInnate Immune SystemImmunologyBacteriophagePathology	2009	126
<i>AdCD40L</i> Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial Per‐Uno Malmström, Angelica Loskog, Camilla A. Lindqvist, Clinical Cancer Research	2010	119
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell–Dependent Tumor Immunity Sara M. Mangsbo, Sissela Broos, Erika Fletcher, Clinical Cancer Research	2014	102
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention Aikaterini Nasi, Stéphanie McArdle, Gustav Gaudernack, Toxicology Reports	2020	98
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer Linda C. Sandin, Anna Orlova, Erika Gustafsson, Cancer Immunology Research ImmunologyPathologyAntigen ProcessingImmunotherapeuticsImmunotherapy	2013	97
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo Linda C. Sandin, Fredrik Eriksson, Peter Ellmark, OncoImmunology T-regulatory CellImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2014	85
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment Emma Eriksson, Rafael Moreno, Ioanna Milenova, Gene Therapy Cell TherapyEndothelial CellsT-regulatory CellImmunologyImmunoediting	2016	83

Page 1